ArticleBMC pharmacology2004

Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.

Lars H Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.